The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Psoriasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
Taylor, W., Gladman, D., Helliwell, P., Marchesoni, A., Mease, P., & Mielants, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21972 · Cited by 3,746
Self-citationGoff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437741.48606.98 · Cited by 3,697
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
Parisi, R., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.339 · Cited by 2,592
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Self-citationPsoriatic arthritis: epidemiology, clinical features, course, and outcome
Gladman, D. D., Antoni, C., Mease, P., Clegg, D. O., & Nash, P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032482 · Cited by 1,536
Self-citationPapp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
Self-citationGuidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Gottlieb, A., Feldman, S. R., Van Voorhees, A. S., Leonardi, C. L., Gordon, K. B., Lebwohl, M., Koo, J. Y. M., Elmets, C. A., Korman, N. J., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.039 · Cited by 1,222
Self-citationEtanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Self-citationT cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.-J., & Gilliet, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050500 · Cited by 1,124
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Collaborative Association Study of Psoriasis (CASP), Tsoi, L. C., Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2, Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2467 · Cited by 1,024
Self-citationPsoriasis of early and late onset: Characterization of two types of psoriasis vulgaris
Henseler, T., & Christophers, E. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70188-0 · Cited by 1,005
Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Marrakchi, S., Guigue, P., Renshaw, B. R., Puel, A., Pei, X.-Y., Fraitag, S., Zribi, J., Bal, E., Cluzeau, C., Chrabieh, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013068 · Cited by 998
Dalgard, F. J., Gieler, U., Tomas-Aragones, L., Lien, L., Poot, F., Jemec, G. B. E., Misery, L., Szabo, C., Linder, D., Sampogna, F., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.530 · Cited by 968
Self-citationMease, P. J., Gladman, D. D., Ritchlin, C. T., Ruderman, E. M., Steinfeld, S. D., Choy, E. H. S., Sharp, J. T., Ory, P. A., Perdok, R. J., & Weinberg, M. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21306 · Cited by 909
Self-citationEfficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Self-citationMcInnes, I. B., Mease, P. J., Kirkham, B., Kavanaugh, A., Ritchlin, C. T., Rahman, P., van der Heijde, D., Landewé, R., Conaghan, P. G., Gottlieb, A. B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61134-5 · Cited by 858
Self-citationGriffiths, C. E. M., Reich, K., Lebwohl, M., van de Kerkhof, P., Paul, C., Menter, A., Cameron, G. S., Erickson, J., Zhang, L., Secrest, R. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60125-8 · Cited by 834
Self-citationPhase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Lebwohl, M., Strober, B., Menter, A., Gordon, K., Weglowska, J., Puig, L., Papp, K., Spelman, L., Toth, D., Kerdel, F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503824 · Cited by 828
Self-citationBeyond GWASs: Illuminating the Dark Road from Association to Function
Edwards, S. L., Beesley, J., French, J. D., & Dunning, A. M. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.012 · Cited by 784
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
Self-citationSano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752
Cronstein, B. N., Naime, D., & Ostad, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116884 · Cited by 679
Papp, K., Reich, K., Leonardi, C. L., Kircik, L., Chimenti, S., Langley, R. G. B., Hu, C., Stevens, R. M., Day, R. M., Gordon, K. B., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.03.049 · Cited by 678
Haroon, M., Gallagher, P., & FitzGerald, O. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204858 · Cited by 626
Langley, R. G., & Ellis, C. N. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.012 · Cited by 614
Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 Gene
Nair, R. P., Stuart, P. E., Nistor, I., Hiremagalore, R., Chia, N. V. C., Jenisch, S., Weichenthal, M., Abecasis, G. R., Lim, H. W., Christophers, E., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503821 · Cited by 606
Self-citationEpidemiology of psoriatic arthritis in the population of the United States
Gelfand, J. M., Gladman, D. D., Mease, P. J., Smith, N., Margolis, D. J., Nijsten, T., Stern, R. S., Feldman, S. R., & Rolstad, T. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.03.046 · Cited by 596
Self-citationGottlieb, A. B., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Baker, D., Bala, M., Marano, C. W., & Menter, A. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.021 · Cited by 581
Self-citationHeterogeneity and plasticity of T helper cells
Zhu, J., & Paul, W. E. (2010) · Cell Research · doi:10.1038/cr.2009.138 · Cited by 568
Dixon, W. G., Watson, K. D., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22809 · Cited by 562
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A. B., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.027 · Cited by 558
Self-citationPsoriasis assessment tools in clinical trials
Feldman, S. R., & Krueger, G. G. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.031237 · Cited by 557
Treatment recommendations for psoriatic arthritis
Ritchlin, C. T., Kavanaugh, A., Gladman, D. D., Mease, P. J., Helliwell, P., Boehncke, W.-H., de Vlam, K., Fiorentino, D., FitzGerald, O., Gottlieb, A. B., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094946 · Cited by 554
Self-citationThaçi, D., Blauvelt, A., Reich, K., Tsai, T.-F., Vanaclocha, F., Kingo, K., Ziv, M., Pinter, A., Hugot, S., You, R., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.013 · Cited by 551
Lebwohl, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12954-6 · Cited by 548
Self-citationOnoufriadis, A., Simpson, M. A., Pink, A. E., Di Meglio, P., Smith, C. H., Pullabhatla, V., Knight, J., Spain, S. L., Nestle, F. O., Burden, A. D., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.022 · Cited by 529
Gordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.027 · Cited by 510
Mease, P. J., Gladman, D. D., Papp, K. A., Khraishi, M. M., Thaçi, D., Behrens, F., Northington, R., Fuiman, J., Bananis, E., Boggs, R., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.07.023 · Cited by 508
Self-citationPaul, C., Cather, J., Gooderham, M., Poulin, Y., Mrowietz, U., Ferrandiz, C., Crowley, J., Hu, C., Stevens, R. M., Shah, K., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14164 · Cited by 484
Self-citationKryczek, I., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Aphale, A., Vatan, L., Szeliga, W., Wang, Y., Liu, Y., Welling, T. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4733 · Cited by 470
Self-citationPapp, K. A., Reich, K., Paul, C., Blauvelt, A., Baran, W., Bolduc, C., Toth, D., Langley, R. G., Cather, J., Gottlieb, A. B., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14493 · Cited by 470
Self-citationPsoriasis Severity and the Prevalence of Major Medical Comorbidity: A Population-Based Study
Yeung, H., Takeshita, J., Mehta, N. N., Kimmel, S. E., Ogdie, A., Margolis, D. J., Shin, D. B., Attor, R., Troxel, A. B., & Gelfand, J. M. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5015 · Cited by 464
Self-citationGuidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A., Koo, J. Y. M., Lebwohl, M., Leonardi, C. L., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.055 · Cited by 460
Self-citationAhlehoff, O., Gislason, G. H., Charlot, M., Jørgensen, C. H., Lindhardsen, J., Olesen, J. B., Abildstrøm, S. Z., Skov, L., Torp-Pedersen, C., & Hansen, P. R. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02310.x · Cited by 441
Quality of Life in Patients with Psoriasis: A Systematic Literature Review
de Korte, J., Mombers, F. M. C., Bos, J. D., & Sprangers, M. A. G. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09110.x · Cited by 441
Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
Schafer, P. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.001 · Cited by 439
Kimball, A. B., Gladman, D., Gelfand, J. M., Gordon, K., Horn, E. J., Korman, N. J., Korver, G., Krueger, G. G., Strober, B. E., & Lebwohl, M. G. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.01.006 · Cited by 432
Self-citationGene for Familial Psoriasis Susceptibility Mapped to the Distal End of Human Chromosome 17q
Tomfohrde, J., Silverman, A., Barnes, R., Fernandez-Vina, M. A., Young, M., Lory, D., Morris, L., Wuepper, K. D., Stastny, P., Menter, A., et al. (1994) · Science · doi:10.1126/science.8178173 · Cited by 426
PSORS2 Is Due to Mutations in CARD14
Jordan, C. T., Cao, L., Roberson, E. D. O., Pierson, K. C., Yang, C.-F., Joyce, C. E., Ryan, C., Duan, S., Helms, C. A., Liu, Y., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.012 · Cited by 416
Self-citationPapp, K. A., Griffiths, C. E. M., Gordon, K., Lebwohl, M., Szapary, P. O., Wasfi, Y., Chan, D., Hsu, M.-C., Ho, V., Ghislain, P. D., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12214 · Cited by 415
Self-citationNast, A., Gisondi, P., Ormerod, A. D., Saiag, P., Smith, C., Spuls, P. I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13354 · Cited by 399
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Mease, P. J., Genovese, M. C., Greenwald, M. W., Ritchlin, C. T., Beaulieu, A. D., Deodhar, A., Newmark, R., Feng, J., Erondu, N., & Nirula, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315231 · Cited by 395
Current severe psoriasis and the Rule of Tens
Finlay, A. Y. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06502.x · Cited by 394
Self-citationArmstrong, A. W., Robertson, A. D., Wu, J., Schupp, C., & Lebwohl, M. G. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5264 · Cited by 386
Self-citationThe risk of melanoma in association with long-term exposure to PUVA
Stern, R. S. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.114576 · Cited by 370
Determinants of quality of life in patients with psoriasis: A study from the US population
Gelfand, J. M., Feldman, S. R., Stern, R. S., Thomas, J., Rolstad, T., & Margolis, D. J. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.014 · Cited by 367
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Ghoreschi, K., Brück, J., Kellerer, C., Deng, C., Peng, H., Rothfuss, O., Hussain, R. Z., Gocke, A. R., Respa, A., Glocova, I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100977 · Cited by 352
Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events
Mehta, N. N., Yu, Y., Pinnelas, R., Krishnamoorthy, P., Shin, D. B., Troxel, A. B., & Gelfand, J. M. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.03.028 · Cited by 345
Self-citationOnset of multiple sclerosis associated with anti-TNF therapy
Sicotte, N. L., & Voskuhl, R. R. (2001) · Neurology · doi:10.1212/wnl.57.10.1885 · Cited by 322
Stuart, P. E., Nair, R. P., Tsoi, L. C., Tejasvi, T., Das, S., Kang, H. M., Ellinghaus, E., Chandran, V., Callis-Duffin, K., Ike, R., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.10.019 · Cited by 319
Self-citationWu, J. J., Poon, K.-Y. T., Channual, J. C., & Shen, A. Y.-J. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.2502 · Cited by 304
Self-citationThe expanding scope of DNA sequencing
Shendure, J., & Aiden, E. L. (2012) · Nature Biotechnology · doi:10.1038/nbt.2421 · Cited by 303
Gudjonsson, J. E., & Elder, J. T. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.08.007 · Cited by 301
Self-citationStern, R. S. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.004 · Cited by 300
Familial occurrence of psoriatic arthritis.
Moll, J. M., & Wright, V (1973) · Annals of the Rheumatic Diseases · doi:10.1136/ard.32.3.181 · Cited by 300
Incidence of psoriasis in children: A population-based study
Tollefson, M. M., Crowson, C. S., McEvoy, M. T., & Maradit Kremers, H. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.07.029 · Cited by 295
Trends in incidence of adult-onset psoriasis over three decades: A population-based study
Icen, M., Crowson, C. S., McEvoy, M. T., Dann, F. J., Gabriel, S. E., & Maradit Kremers, H. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.10.062 · Cited by 286
Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis
Gutierrez‐Ureña, S., Molina, J. F., García, C. O., Cuéllar, M. L., & Espinoza, L. R. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390214 · Cited by 279
The future of industrial bioprocessing: Batch or continuous?
Croughan, M. S., Konstantinov, K. B., & Cooney, C. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25529 · Cited by 234
Acitretin in psoriasis: An overview of adverse effects
Katz, H. I., Waalen, J., & Leach, E. E. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70359-2 · Cited by 232
Zachariae, H., Zachariae, R., Blomqvist, K., Davidsson, S., Molin, L., Mørk, C., & Sigurgeirsson, B. (2002) · Acta Dermato-Venereologica · doi:10.1080/00015550252948130 · Cited by 220
Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and Its Clinical Subtypes
Okada, Y., Han, B., Tsoi, L. C., Stuart, P. E., Ellinghaus, E., Tejasvi, T., Chandran, V., Pellett, F., Pollock, R., Bowcock, A. M., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.07.002 · Cited by 215
Self-citationLizzul, P. F., Aphale, A., Malaviya, R., Sun, Y., Masud, S., Dombrovskiy, V., & Gottlieb, A. B. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23735.x · Cited by 212
Self-citationYin, X., Low, H. Q., Wang, L., Li, Y., Ellinghaus, E., Han, J., Estivill, X., Sun, L., Zuo, X., Shen, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7916 · Cited by 204
Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
Tsoi, L. C., Spain, S. L., Ellinghaus, E., Stuart, P. E., Capon, F., Knight, J., Tejasvi, T., Kang, H. M., Allen, M. H., Lambert, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8001 · Cited by 195
Self-citationMethotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and Degradation
Majumdar, S., & Aggarwal, B. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2911 · Cited by 192
Familial aggregation of psoriatic arthritis
Chandran, V, Schentag, C. T., Brockbank, J. E., Pellett, F. J., Shanmugarajah, S., Toloza, S. M. A., Rahman, P., & Gladman, D. D. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089367 · Cited by 192
Self-citationBowes, J., Budu-Aggrey, A., Huffmeier, U., Uebe, S., Steel, K., Hebert, H. L., Wallace, C., Massey, J., Bruce, I. N., Bluett, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7046 · Cited by 187
AP1S3 Mutations Are Associated with Pustular Psoriasis and Impaired Toll-like Receptor 3 Trafficking
Setta-Kaffetzi, N., Simpson, M. A., Navarini, A. A., Patel, V. M., Lu, H.-C., Allen, M. H., Duckworth, M., Bachelez, H., Burden, A. D., Choon, S.-E., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.04.005 · Cited by 186
The IL-23/IL-17 axis in psoriatic arthritis
Suzuki, E., Mellins, E. D., Gershwin, M. E., Nestle, F. O., & Adamopoulos, I. E. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.050 · Cited by 186
Rosenberg, P., Urwitz, H., Johannesson, A., Ros, A.-M., Lindholm, J., Kinnman, N., & Hultcrantz, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.024 · Cited by 185
Heritability of psoriasis in a large twin sample
Lønnberg, A. S., Skov, L., Skytthe, A., Kyvik, K. O., Pedersen, O. B., & Thomsen, S. F. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12375 · Cited by 183
IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
Chiricozzi, A., Nograles, K. E., Johnson-Huang, L. M., Fuentes-Duculan, J., Cardinale, I., Bonifacio, K. M., Gulati, N., Mitsui, H., Guttman-Yassky, E., Suárez-Fariñas, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090284 · Cited by 180
Psoriasis has a major secondary impact on the lives of family members and partners
Eghlileb, A. M., Davies, E. E. G., & Finlay, A. Y. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07881.x · Cited by 177
Self-citationAhlehoff, O., Skov, L., Gislason, G., Lindhardsen, J., Kristensen, S. L., Iversen, L., Lasthein, S., Gniadecki, R., Dam, T. N., Torp‐Pedersen, C., et al. (2013) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02593.x · Cited by 177
Chandran, V., Cook, R. J., Edwin, J., Shen, H., Pellett, F. J., Shanmugarajah, S., Rosen, C. F., & Gladman, D. D. (2010) · Rheumatology · doi:10.1093/rheumatology/keq105 · Cited by 175
Self-citationWakkee, M., Herings, R. M. C., & Nijsten, T. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.321 · Cited by 173
Rare Pathogenic Variants in IL36RN Underlie a Spectrum of Psoriasis-Associated Pustular Phenotypes
Setta-Kaffetzi, N., Navarini, A. A., Patel, V. M., Pullabhatla, V., Pink, A. E., Choon, S.-E., Allen, M. A., Burden, A. D., Griffiths, C. E. M., Seyger, M. M. B., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.490 · Cited by 172
Doherty, S. D., Van Voorhees, A., Lebwohl, M. G., Korman, N. J., Young, M. S., & Hsu, S. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.03.023 · Cited by 171
Self-citationAntidrug antibodies in psoriasis: a systematic review
Hsu, L., Snodgrass, B. T., & Armstrong, A. W. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12654 · Cited by 164
Reich, K., Ortonne, J.-P., Gottlieb, A. B., Terpstra, I. J., Coteur, G., Tasset, C., & Mease, P. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10941.x · Cited by 158
Self-citationThe prevalence of psoriasis in the Mongoloid race
Yip, S. Y. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80314-x · Cited by 153
Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis
Zuo, X., Sun, L., Yin, X., Gao, J., Sheng, Y., Xu, J., Zhang, J., He, C., Qiu, Y., Wen, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms7793 · Cited by 151
Self-citationVeal, C., Capon, F., Allen, M. H., Heath, E., Evans, J., Jones, A., Patel, S., Burden, A. D., Tillman, D. M., Barker, J. N. W. N., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342289 · Cited by 151
Biomarkers in psoriasis and psoriatic arthritis
Villanova, F., Meglio, P. D., & Nestle, F. O. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203037 · Cited by 150
Lee, Y., Rüschendorf, F., Windemuth, C., Schmitt‐Egenolf, M., Stadelmann, A., Nürnberg, G., Ständer, M., Wienker, T. F., Reis, A., & Traupe, H. (2000) · The American Journal of Human Genetics · doi:10.1086/303075 · Cited by 147
Veal, C., Clough, R. L., Barber, R. C., et al. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.1.7 · Cited by 142
The Children's Dermatology Life Quality Index: validation of the cartoon version
Holme, S. A., Man, I., Sharpe, J., Dykes, P. J., Lewis‐Jones, M. S., & Finlay, A. Y. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05157.x · Cited by 141
Self-citationConsensus conference: Acitretin in combination with UVB or PUVA in the treatment of psoriasis
Lebwohl, M. G., Drake, L. A., Menter, A., Koo, J. Y. M., Gottlieb, A. B., Zanolli, M. D., Young, M. S., & McClelland, P. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.116347 · Cited by 139
Self-citationTazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis
Lebwohl, M., Breneman, D., Goffe, B. S., et al. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70008-8 · Cited by 137
Self-citationTranscription-Factor Mutations and Disease
Latchman, D. S. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340108 · Cited by 133
Dowlatshahi, E. A., Kavousi, M., Nijsten, T. E. C., Ikram, M. A., Albert Hofman, D., Franco, O. H., & Wakkee, M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.131 · Cited by 131
Comorbidities in Psoriasis Patients
Kim, N., Thrash, B., & Menter, A. (2010) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2010.01.002 · Cited by 126
Research gaps in psoriasis: Opportunities for future studies
Ryan, C., Korman, N. J., Gelfand, J. M., Lim, H. W., Elmets, C. A., Feldman, S. R., Gottlieb, A. B., Koo, J. Y. M., Lebwohl, M., Leonardi, C. L., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.08.042 · Cited by 120
Self-citationHumanized anti–IFN-γ (HuZAF) in the treatment of psoriasis
Harden, J. L., Johnson-Huang, L. M., Chamian, F., Lee, E., Pearce, T. E., Leonardi, C. L., Haider, A. S., Lowes, M. A., & Krueger, J. G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.046 · Cited by 118
McGill, A., Frank, A., Emmett, N., Leech, S. N., Turnbull, D. M., Birch‐Machin, M. A., & Reynolds, N. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2664fje · Cited by 117
Rahman, M., Akhter, S., Ahmad, J., Ahmad, M. Z., Beg, S., & Ahmad, F. J. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.982088 · Cited by 113
Renal biopsy findings in long-term cyclosporin treatment of psoriasis
ZACHARIAE, H., Kragballe, K., Hansen, H. E., Marcussen, N., & Olsen, S. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.6101586.x · Cited by 109
Iskandar, I. Y. K., Ashcroft, D. M., Warren, R. B., Yiu, Z. Z. N., McElhone, K., Lunt, M., Barker, J. N., Burden, A. D., Ormerod, A. D., Reynolds, N. J., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13908 · Cited by 107
Sagoo, G. S., Ahnini, R. T., Barker, J. W. N., Elder, J. T., Nair, R. P., Samuelsson, L., Traupe, H., Trembath, R. C., Robinson, D. A., & Iles, M. M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22607.x · Cited by 106
Self-citationPsoriasis in Norwegian twins: contribution of genetic and environmental effects
Grjibovski, A. M., Olsen, A., Magnus, P. M., & Harris, J. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02268.x · Cited by 94
Jókai, H., Szakonyi, J., Kontár, O., Marschalkó, M., Szalai, K., Kárpáti, S., & Holló, P. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.06.019 · Cited by 91
Mahil, S. K., Capon, F., & Barker, J. N. (2014) · Dermatologic Clinics · doi:10.1016/j.det.2014.09.001 · Cited by 90
The Challenge of Dermato-Epidemiology
Williams, H. C., & Strachan, D. P. (1997) · Cited by 89
Fan, X., Yang, S., Huang, W., Wang, Z., Sun, L., Liang, Y., Gao, M., Ren, Y.-Q., Zhang, K.-Y., Du, W.-H., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000038 · Cited by 89
Kim, T., Jee, H., Fuentes‐Duculan, J., Wu, W. H., Byamba, D., Kim, D., Kim, D. Y., Lew, D., Yang, W.-I., Krueger, J. G., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.534 · Cited by 88
Recurrence risk for psoriasis and psoriatic arthritis within sibships
Myers, A., Kay, L., Lynch, S. A., & Walker, D. J. (2005) · Rheumatology · doi:10.1093/rheumatology/keh589 · Cited by 84
Bowes, J., Löhr, S., Budu‐Aggrey, A., Uebe, S., Bruce, I. N., Feletar, M., Marzo‐Ortega, H., Helliwell, P., Ryan, A. W., Kane, D. J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207187 · Cited by 83
Zweegers, J., van den Reek, J. M. P. A., van de Kerkhof, P. C. M., Otero, M. E., Kuijpers, A. L. A., Koetsier, M. I. A., Arnold, W. P., Berends, M. A. M., Parren, L. J. M. T., Ossenkoppele, P. M., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14552 · Cited by 81
Lee, Y. W., Park, E. J., Kwon, I. H., Kim, K. H., & Kim, K. J. (2010) · Annals of Dermatology · doi:10.5021/ad.2010.22.4.389 · Cited by 80
Arbiser, J. L., Govindarajan, B., Battle, T. E., Lynch, R. A., Frank, D. A., Ushio‐Fukai, M., Perry, B. N., Stern, D. F., Bowden, G. T., Liu, A., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700276 · Cited by 78
Bissonnette, R., Tardif, J., Harel, F., Pressacco, J., Bolduc, C., & Guertin, M. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.975730 · Cited by 76
Man, X., Yang, X., Cai, S., Bu, Z., & Zheng, M. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00112.x · Cited by 73
Latitude and psoriasis prevalence
Jacobson, C. C., Kumar, S., & Kimball, A. B. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.05.047 · Cited by 73
Ali, F. M., Cueva, A., Vyas, J., Atwan, A. A., Salek, S., Finlay, A. Y., & Piguet, V. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14788 · Cited by 68
Self-citationElyoussfi, S., Thomas, B. J., & Ciurtin, C. (2016) · Rheumatology International · doi:10.1007/s00296-016-3436-0 · Cited by 63
Ling, Y., & Puel, A. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(14)70016-x · Cited by 54
The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients
Young, M. S., Horn, E. J., & Cather, J. C. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.92 · Cited by 51
Gottlieb, A. B., Levin, A. A., Armstrong, A. W., Abernethy, A., Duffin, K. C., Bhushan, R., Garg, A., Merola, J. F., Maccarone, M., & Christensen, R. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.11.002 · Cited by 50
Self-citationSwindell, W. R., Sarkar, M. K., Stuart, P. E., Voorhees, J. J., Elder, J. T., Johnston, A., & Gudjonsson, J. E. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0054-5 · Cited by 47
Self-citationThe infliximab biosimilar in the treatment of moderate to severe plaque psoriasis
Dapavo, P., Vujic, I., Fierro, M. T., Quaglino, P., & Sanlorenzo, M. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.04.068 · Cited by 47
Niu, X., Cao, W. W., Ma, H., Feng, J., Ximei, L. I., & Zhang, X. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2012.01637.x · Cited by 45
Barriers to guideline‐compliant psoriasis care: analyses and concepts
Eissing, L., Radtke, M. A., Zander, N., & Augustin, M. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13452 · Cited by 45
Zweegers, J., Otero, M., van den Reek, J. M. P. A., van Lümig, P. P. M., Driessen, R. S., Kievit, W., Seyger, M. M. B., van de Kerkhof, P. C. M., & de Jong, E. M. G. J. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2276 · Cited by 41
Eghlileb, A. M., Basra, M. K. A., & Finlay, A. Y. (2009) · Dermatology · doi:10.1159/000209234 · Cited by 40
Self-citationStein, K. R., Pearce, D. J., & Feldman, S. R. (2005) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2005.01.004 · Cited by 37
Larsen, M. H., Hagen, K. B., Krogstad, A., Aas, E., & Wahl, A. K. (2013) · Patient Education and Counseling · doi:10.1016/j.pec.2013.10.005 · Cited by 37
Imafuku, S., Naito, R., & NAKAYAMA, J. (2013) · The Journal of Dermatology · doi:10.1111/1346-8138.12240 · Cited by 36
Psoriasis during pregnancy: characteristics and important management recommendations
Hoffman, M. B., Farhangian, M. E., & Feldman, S. R. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1037742 · Cited by 36
Thorleifsdottir, R. H., Sigurdardottir, S. L., Sigurgeirsson, B., Ólafsson, J., Petersen, H., Sigurdsson, M. I., Gudjonsson, J. E., Johnston, A., & Valdimarsson, H. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.06.061 · Cited by 34
Bhatti, Z., Finlay, A. Y., Bolton, C. E., George, L., Halcox, J., Jones, S., Ketchell, R. I., Moore, R. H., & Salek, S. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12289 · Cited by 30
Self-citationArmstrong, A. W., Gelfand, J. M., Boehncke, W., & Armstrong, E. J. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.130457 · Cited by 27
Novel systemic therapies for the treatment of psoriasis
Tan, K. W., & Griffiths, C. E. M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1109636 · Cited by 20
Tsoi, L. C., Elder, J. T., & Abecasis, G. R. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu799 · Cited by 12
Self-citationMozzi, P. D., Johnston, G. A., & ALEXANDROFF, A. B. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10767.x · Cited by 7
Measuring Family Impact of Skin Diseases: FDLQI and FROM-16
Finlay, A. Y., Salek, S., & Piguet, V. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2121 · Cited by 6
Self-citation
Cited by
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Ghoreschi, K., Balato, A., Enerbäck, C., & Sabat, R. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00184-7 · Cited by 668
Advances in the pathogenesis of psoriasis: from keratinocyte perspective
Zhou, X., Chen, Y., Cui, L., Shi, Y., & Guo, C. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04523-3 · Cited by 632
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Li, H., Zuo, J., & Tang, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01048 · Cited by 580
Sabat, R., Jemec, G. B. E., Matusiak, Ł., Kimball, A. B., Prens, E., & Wolk, K. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0149-1 · Cited by 573
Tsoi, L. C., Rodriguez, E., Degenhardt, F., Baurecht, H., Wehkamp, U., Volks, N., Szymczak, S., Swindell, W. R., Sarkar, M. K., Raja, K., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.12.018 · Cited by 469
Self-citation
Metadata
- Authors
- Greb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M. G., Gladman, D. D., Wu, J. J., Mehta, N. N., Finlay, A. Y., & Gottlieb, A. B.
- Venue
- Nature Reviews Disease Primers
- Published
- 2016-11-24
- Volume
- 2
- Issue
- 1
- Pages
- 16082-16082
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211202219
- Cited by
- 922
- References
- 155
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.